Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hynes

Showing results (31-40 of 275) with videos related to

Pageof 28
Sort By:
Plos Biology|September 30, 2016
Breast Cancer Patients Have Greatly Benefited from the Progress in Molecular OncologyBernd L Groner, Nancy E Hynes
Nature Reviews. Cancer|May 3, 2005
ERBB receptors and cancer: the complexity of targeted inhibitorsNancy E Hynes, Heidi A Lane
Journal of Bacteriology|October 1, 1976
Rate of synthesis of polyadenylate-containing ribonucleic acid during the yeast cell cycleN E Hynes, S L Phillips
Child Welfare|November 1, 1980
Fostering self-esteem in families with diabetic childrenE M Hill, J E Hynes
Cold Spring Harbor Perspectives in Biology|June 18, 2010
Mammary gland growth factors: roles in normal development and in cancerNancy E Hynes, Christine J Watson
The Journal of Biological Chemistry|March 15, 1996
Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activitiesR R Beerli, N E Hynes
Cancer Cell|May 5, 2009
PI3K inhibition overcomes trastuzumab resistance: blockade of ErbB2/ErbB3 is not always enoughNancy E Hynes, Julien H Dey
Biochimica Et Biophysica Acta|December 30, 1994
The biology of erbB-2/neu/HER-2 and its role in cancerN E Hynes, D F Stern
Journal of Mammary Gland Biology and Neoplasia|July 27, 2001
Myc and mammary cancer: Myc is a downstream effector of the ErbB2 receptor tyrosine kinaseN E Hynes, H A Lane
Biochemical and Biophysical Research Communications|January 13, 1997
Characterization of scFv-421, a single-chain antibody targeted to p53C B Jannot, N E Hynes
Pageof 28

Showing results (31-40 of 275) with videos related to

Sort By:
Pageof 28
Plos Biology|September 30, 2016
Breast Cancer Patients Have Greatly Benefited from the Progress in Molecular OncologyBernd L Groner, Nancy E Hynes
Nature Reviews. Cancer|May 3, 2005
ERBB receptors and cancer: the complexity of targeted inhibitorsNancy E Hynes, Heidi A Lane
Journal of Bacteriology|October 1, 1976
Rate of synthesis of polyadenylate-containing ribonucleic acid during the yeast cell cycleN E Hynes, S L Phillips
Child Welfare|November 1, 1980
Fostering self-esteem in families with diabetic childrenE M Hill, J E Hynes
Cold Spring Harbor Perspectives in Biology|June 18, 2010
Mammary gland growth factors: roles in normal development and in cancerNancy E Hynes, Christine J Watson
The Journal of Biological Chemistry|March 15, 1996
Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activitiesR R Beerli, N E Hynes
Cancer Cell|May 5, 2009
PI3K inhibition overcomes trastuzumab resistance: blockade of ErbB2/ErbB3 is not always enoughNancy E Hynes, Julien H Dey
Biochimica Et Biophysica Acta|December 30, 1994
The biology of erbB-2/neu/HER-2 and its role in cancerN E Hynes, D F Stern
Journal of Mammary Gland Biology and Neoplasia|July 27, 2001
Myc and mammary cancer: Myc is a downstream effector of the ErbB2 receptor tyrosine kinaseN E Hynes, H A Lane
Biochemical and Biophysical Research Communications|January 13, 1997
Characterization of scFv-421, a single-chain antibody targeted to p53C B Jannot, N E Hynes
Pageof 28